Literature DB >> 19142359

Comparative costs between myocardial revascularization with or without extracorporeal circulation.

Priscyla B M A Girardi1, Whady Hueb, Célia R S R Nogueira, Myrthes E Takiuti, Teryo Nakano, Cibele Larrosa Garzillo, Felipe da S Paulitsch, Aécio F T Góis, Neuza H M Lopes, Noedir A Stolf.   

Abstract

BACKGROUND: Surgical techniques of myocardial revascularization without the use of extracorporeal circulation (ECC) have raised hopes of attaining operative results with less systemic damage, lower occurrence of clinical complications and shorter hospital stay duration, generating expectations of lower hospital costs.
OBJECTIVE: To evaluate the hospital costs in patients submitted to myocardial revascularization with and without ECC and in those with stable multiarterial coronary disease with preserved ventricular function.
METHODS: The hospital costs were based on the existing governmental reimbursement. The costs included that of ortheses and prostheses and clinical complications. The time and costs of ICU stay and hospital stay duration were considered.
RESULTS: Between January 2002 and August 2006, 131 patients were randomized to surgery with ECC (SECC), whereas 128 were randomized to surgery without ECC (WECC). The basal characteristics were similar for both groups. The costs of surgical complications were significantly lower (p < 0.001) in patients from the WECC when compared to the SECC group (606.00 +/- 525.00 vs. 945.90 +/- 440.00), as well as ICU costs: 432.20 +/- 391.70 vs. 717.70 +/- 257.70, respectively. The duration of the operating room stay were 4.9 +/- 1.1 h vs. 3.9 +/- 1.0 h, p < 0.001; at the ICU it was 48.2 +/- 17.2 h vs. 29.2 +/- 26.1h) (p < 0.001), with intubation time of 9.2 +/- 4.5 h vs. 6.4 +/- 5.1h, p < 0.001 for patients from the group with and without ECC, respectively.
CONCLUSION: The present study allowed us to conclude that the myocardial revascularization surgery without extracorporeal circulation results in the decrease of operational costs and duration of the stay in each section related to the surgical treatment.

Entities:  

Mesh:

Year:  2008        PMID: 19142359     DOI: 10.1590/s0066-782x2008001800003

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  5 in total

Review 1.  A Systematic Review of Cardiovascular Outcomes-Based Cost-Effectiveness Analyses of Lipid-Lowering Therapies.

Authors:  Ching-Yun Wei; Ruben G W Quek; Guillermo Villa; Shravanthi R Gandra; Carol A Forbes; Steve Ryder; Nigel Armstrong; Sohan Deshpande; Steven Duffy; Jos Kleijnen; Peter Lindgren
Journal:  Pharmacoeconomics       Date:  2017-03       Impact factor: 4.981

Review 2.  Patient-level costs of major cardiovascular conditions: a review of the international literature.

Authors:  Gina Nicholson; Shravanthi R Gandra; Ronald J Halbert; Akshara Richhariya; Robert J Nordyke
Journal:  Clinicoecon Outcomes Res       Date:  2016-09-21

3.  Hemodynamic Changes During Heart Displacement in Aorta No-Touch Off-Pump Coronary Artery Bypass Surgery: A Pilot Study.

Authors:  Alexandre R Carvalho; Solange Guizilini; Gustavo M Murai; Isis Begot; Isadora S Rocco; Nelson A Hossne; Eduardo G Chamlian; João Manoel T Santos; Ricardo A Macedo; Gustavo C O Lisboa; Alberto C Nasciutti; Carlos Eduardo R Santos; João Paulo M Figueiredo; Walter J Gomes
Journal:  Braz J Cardiovasc Surg       Date:  2018 Sep-Oct

4.  Coronary Artery Bypass Graft Surgery Cost Coverage by the Brazilian Unified Health System (SUS).

Authors:  Gilmara Silveira da Silva; Flávia Cortez Colósimo; Alexandre Gonçalves de Sousa; Raquel Ferrari Piotto; Valéria Castilho
Journal:  Braz J Cardiovasc Surg       Date:  2017 Jul-Aug

5.  On- or Off-pump Coronary Artery Bypass Surgery. Is the Debate Settling Down?

Authors:  Walter J Gomes; Gianni D Angelini
Journal:  Braz J Cardiovasc Surg       Date:  2019-08-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.